Cardiac amyloidosis: Diagnostic features and clinical implications
M S Nouh1, M M Al-Nozha, A Y Qaraqish
1Department of Medicine, Cardiology Division, College of Medicine, King Khaled University Hospital, Riyadh, Saudi Arabia.
Cardiac amyloidosis patients developed congestive heart failure due to impaired diastolic function, not systolic dysfunction. This finding highlights diastolic dysfunction as a key mechanism in cardiac amyloidosis progression.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Nephrology
Background:
- Cardiac amyloidosis is a progressive infiltrative disease.
- Congestive heart failure is a common complication.
Purpose of the Study:
- To investigate the mechanism of congestive heart failure in cardiac amyloidosis patients.
- To assess cardiac function in patients with cardiac amyloidosis.
Main Methods:
- Retrospective analysis of seven cardiac amyloidosis patients.
- Echocardiographic assessment of ventricular wall thickness and systolic/diastolic function.
Main Results:
- All patients presented with congestive heart failure.
- Patients exhibited thickened ventricular walls and abnormal left ventricular filling.
- Systolic function was preserved, while diastolic dysfunction was evident.
Conclusions:
- Diastolic dysfunction is a primary mechanism contributing to congestive heart failure in cardiac amyloidosis.
- Early identification of diastolic dysfunction is crucial for managing cardiac amyloidosis.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
